Direct Acting Antivirals
Direct Acting Antivirals is a pharmaceutical drug with 10 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 1 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
0
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
33.3%
1 of 3 finished
66.7%
2 ended early
1
trials recruiting
10
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
The Treatment in Pregnancy for Hepatitis C ("TiP-HepC") Registry
Hepatitis C Positive Donor Into Hepatitis C Negative Recipients
HCV + to HCV - Kidney Transplant
Possible Differences in HCC Course Depending on DAA Treatment
Treatment of Hepatitis c by Using Direct-acting Antiviral
Clinical Trials (10)
The Treatment in Pregnancy for Hepatitis C ("TiP-HepC") Registry
Hepatitis C Positive Donor Into Hepatitis C Negative Recipients
HCV + to HCV - Kidney Transplant
Possible Differences in HCC Course Depending on DAA Treatment
Treatment of Hepatitis c by Using Direct-acting Antiviral
HCV RAS Testing in Public Health Programs
An Observational Study of the Safety of Direct-acting Antivirals in Patients With Hepatitis C
Frequency of Anxiety and Depression in Chronic Hepatitis C Patients Recieving Direct-Acting Antiviral Agents
DAA Therapy in Pediatric Patients With Chronic Hepatitis C
Management of Patients With Hepatitis C in a Public Health Care Setting: The Punjab Model
All 10 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 10